Drug Type Monoclonal antibody |
Synonyms TRG 035, TRG035 |
Target |
Mechanism SOSTDC1 inhibitors(sclerostin domain containing 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Toregem BioPharma Co., Ltd.Startup |
Active Organization Toregem BioPharma Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Periodontal Diseases | Preclinical | JP | Toregem BioPharma Co., Ltd.Startup | - |